fluconazole
Generic: fluconazole
Labeler: pharmasource meds, llcDrug Facts
Product Profile
Brand Name
fluconazole
Generic Name
fluconazole
Labeler
pharmasource meds, llc
Dosage Form
TABLET
Routes
Active Ingredients
fluconazole 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
82982-070
Product ID
82982-070_198ba216-39a2-3d98-e063-6394a90a9f0b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA077731
Marketing Start
2023-06-13
Marketing End
2027-06-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
82982070
Hyphenated Format
82982-070
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fluconazole (source: ndc)
Generic Name
fluconazole (source: ndc)
Application Number
ANDA077731 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 2 TABLET in 1 BLISTER PACK (82982-070-02)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "198ba216-39a2-3d98-e063-6394a90a9f0b", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "unii": ["8VZV102JFY"], "rxcui": ["197699"], "spl_set_id": ["fe0cc56d-c0b6-f859-e053-6294a90ad932"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Pharmasource Meds, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET in 1 BLISTER PACK (82982-070-02)", "package_ndc": "82982-070-02", "marketing_end_date": "20270630", "marketing_start_date": "20230613"}], "brand_name": "Fluconazole", "product_id": "82982-070_198ba216-39a2-3d98-e063-6394a90a9f0b", "dosage_form": "TABLET", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "82982-070", "generic_name": "Fluconazole", "labeler_name": "Pharmasource Meds, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "150 mg/1"}], "application_number": "ANDA077731", "marketing_category": "ANDA", "marketing_end_date": "20270630", "marketing_start_date": "20230613"}